Keros Therapeutics

Develops protein therapeutics for hematological and musculoskeletal disorders.

Founded 2015 · 82 employees · United States · Public

Listed:

NASDAQ: KROS

Subsidiaries:

Keros Therapeutics Australia Pty Ltd, Keros Security Corporation